Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of atorvastatin on osteoprotegerin-RANKL system and vascular stiffness in type 2 diabetes
2007-004368-34Phase 4Completed
- Sponsor
- Beaumont Hospital Dublin
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of atorvastatin in type 2 diabetes mellitus (T2DM) and arteriosclerosis, sponsored by Beaumont Hospital Dublin. Primary endpoint: Serum osteoprotegerin and RANKL levels. Started Jun 2008; status: completed.
02
Drugs
atorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)arteriosclerosis
Beyond the preview
Go deeper on 2007-004368-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004368-34.